Advertisement

Topics

Expert Discusses Frontline Standards, Dosing, and Novel Agents in Pancreatic Cancer

09:13 EST 6 Mar 2019 | OncLive

Benjamin Weinberg, MD, discusses frontline standards of care in metastatic pancreatic cancer and highlights emerging agents targeting the stroma.

Original Article: Expert Discusses Frontline Standards, Dosing, and Novel Agents in Pancreatic Cancer

NEXT ARTICLE

More From BioPortfolio on "Expert Discusses Frontline Standards, Dosing, and Novel Agents in Pancreatic Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...